Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -22,479 | -15,502 | -9,358 | 0 |
| Depreciation Amortization | 568 | 337 | 163 | 0 |
| Accounts payable and accrued liabilities | 249 | 226 | 83 | N/A |
| Other Working Capital | 1,487 | 965 | 114 | 0 |
| Other Operating Activity | 1,662 | 3,565 | 4,443 | 0 |
| Operating Cash Flow | $-18,513 | $-10,409 | $-4,555 | $0 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 14,001 | 9,000 | 3,999 | N/A |
| PPE Investments | -1,177 | -558 | -120 | 0 |
| Other Investing Activity | -390 | -286 | 37 | 0 |
| Investing Cash Flow | $12,434 | $8,156 | $3,916 | $0 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | -247 | N/A | N/A |
| Common Stock Issued | -1,340 | 363 | N/A | N/A |
| Other Financing Activity | 34,097 | 34,097 | 2,311 | 0 |
| Financing Cash Flow | $32,757 | $34,213 | $2,311 | $0 |
| Exchange Rate Effect | 3 | 2 | 3 | 0 |
| Beginning Cash Position | 4,477 | 4,477 | 4,477 | 0 |
| End Cash Position | 31,158 | 36,439 | 6,152 | 0 |
| Net Cash Flow | $26,681 | $31,962 | $1,675 | $0 |
| Free Cash Flow | ||||
| Operating Cash Flow | -18,513 | -10,409 | -4,555 | 0 |
| Capital Expenditure | -1,177 | -558 | -120 | N/A |
| Free Cash Flow | -19,690 | -10,967 | -4,675 | 0 |